Latest Strategy News

WCM Global Growth Limited has declared a fully franked quarterly dividend of AUD 0.0206 per share, accompanied by an attractive Dividend Reinvestment Plan featuring a combined 5% discount and a unique 2% incentive.

WCM Global Growth Limited reported a robust 53% rise in net profit for FY2025, driven by strong portfolio returns and a successful capital raise, prompting an increased final dividend and upward revision of future dividends.

Microba Life Sciences reported a 30% increase in revenue to $15.7 million for FY25, driven by strong growth in its core microbiome diagnostic products and successful UK market expansion. Despite narrowing its net loss to $14.9 million, the company is focused on scaling diagnostics adoption and achieving break-even in FY26.

Hazer Group has reported a remarkable FY25 performance with revenues more than doubling and losses slashed by 60%, underpinned by a strategic partnership with KBR and early commercial revenues.

Hazer Group Limited reported a 124% surge in revenues to $8.5 million for FY25, driven by government grants, while cutting its net loss by 60%. The company advanced its proprietary methane pyrolysis technology, secured a strategic alliance with KBR, and made progress on key projects in Canada and Japan.

WAM Active Limited reported a robust 26.4% increase in its investment portfolio for FY2025, significantly outperforming key benchmarks, while maintaining its fully franked dividend at 6.0 cents per share.

Elanor Commercial Property Fund reported a statutory loss for FY25 but delivered a 6.9% rise in Funds from Operations, while rejecting an unsolicited takeover offer from the Lederer Group.

WAM Active Limited reported a robust FY2025 with a 26.4% investment portfolio gain and a steady fully franked dividend of 6.0 cents per share, underscoring its active management approach amid evolving market conditions.

Starpharma reports a significant 183% jump in FY25 revenue to $4.9 million, alongside a 31% reduction in losses and a solid cash position of $15.4 million. The biotech firm’s progress underscores growing momentum in its dendrimer technology pipeline.

Elanor Commercial Property Fund reported a solid FY25 with strong income and portfolio stability, while rejecting an unsolicited takeover bid from Lederer Group.

Havilah Resources has unveiled detailed plans for developing two significant copper deposits in South Australia’s Curnamona Province, highlighting robust resource bases and strategic infrastructure advantages.

Elanor Commercial Property Fund has met its FY25 earnings guidance with robust leasing activity and a strong occupancy rate, setting a stable foundation for FY26 despite market headwinds.